Evidence map›Paper›PMID 35479531›Full record

ReviewRSC advances2021

Cyclodextrins: promising scaffolds for MRI contrast agents.

Berthe Sandra Sembo-Backonly, François Estour, Géraldine Gouhier

Abstract readReview
In one paragraph

Review in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Gadolinium(III) complex formation with a β-cyclodextrin ligand: an XAS study of a potential MRI contrast agent.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2023
    Article
  5. Review
  6. Pretargeting with Cucurbituril-Adamantane Host-Guest Pair in Xenograft Models.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Berthe Sandra Sembo-BackonlyNormandie Université, COBRA UMR 6014, FR 3038, INSA Rouen, CNRS, IRCOF 1 Rue Tesnière 76821 Mont-Saint-Aignan France geraldine.gouhier@univ-rouen.fr.ORCID https://orcid.org/0000-0003-1190-1210
François EstourNormandie Université, COBRA UMR 6014, FR 3038, INSA Rouen, CNRS, IRCOF 1 Rue Tesnière 76821 Mont-Saint-Aignan France geraldine.gouhier@univ-rouen.fr.ORCID https://orcid.org/0000-0002-6304-8920
Géraldine GouhierNormandie Université, COBRA UMR 6014, FR 3038, INSA Rouen, CNRS, IRCOF 1 Rue Tesnière 76821 Mont-Saint-Aignan France geraldine.gouhier@univ-rouen.fr.ORCID https://orcid.org/0000-0002-3852-1827

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magnetic resonance imaging (MRI) is a powerful tool for non-invasive, high-resolution three-dimensional medical imaging of anatomical structures such as organs and tissues. The use of contrast agents based on gadolinium chelates started in 1988 to improve the quality of the image, since researchers and industry focused their attention on the development of more efficient and stable structures. This review is about the state of the art of MRI contrast agents based on cyclodextrin scaffolds. Chemical engineering strategies are herein reported including host-guest inclusion complexation and covalent linkages. It also offers descriptions of the MRI properties and

Identifiers

PMID35479531
PMCPMC9040919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.